Lunenfeld-Tanenbaum Research Institute

Last updated
Lunenfeld-Tanenbaum Research Institute
Lunenfeld-Tanenbaum Research Institute logo - SHS version.png
Established1985
Research typeMedical
Director of Research
Dr. Anne-Claude Gingras
Address600 University Ave.
Location Toronto, Ontario, Canada
Affiliations University of Toronto
Operating agency
Sinai Health System
Website www.lunenfeld.ca
Former logo of the Institute Lunenfeld-Tanenbaum Research Institute Logo June 25, 2013.png
Former logo of the Institute

The Lunenfeld-Tanenbaum Research Institute is a medical research institute in Toronto, Ontario and part of the Sinai Health System. It was originally established in 1985 as the Samuel Lunenfeld Research Institute, the research arm of Mount Sinai Hospital, by an endowment from the Lunenfeld and Kunin families. It was renamed to the current name on June 24, 2013, after a $35 million donation from Larry and Judy Tanenbaum.

Contents

It comprises 36 principal investigators, has a budget of C$90 million (2005/6), has over 200 trainees and approximately 600 staff. [1] The institute conducts research into various forms of cancer (colon, breast, pancreatic, prostate, lung, etc.), neurological disorders and brain illnesses, women's and infants' health, diabetes, developmental biology, stem cell biology and tissue regeneration, mouse models of human disease, genomic medicine and systems biology. The institute has 100,000 sq ft (9,300 m2) of space and is split between the main hospital and the Joseph and Wolf Lebovic Health Complex.

The Lunenfeld-Tanenbaum Research Institute is a world pioneer in the fields of Systems Biology, Diabetes, and Infectious Bowel Disease. Its Systems Biology team consistently ranked Top 5 worldwide. Researchers at the Lunenfeld have the highest per capita funding and citations in Canada.

The founding director was Louis Siminovitch (1984–1994), followed by Alan Bernstein (1995–2000), Janet Rossant and Anthony Pawson (2001–2002), Anthony Pawson (2002–2005), James Woodgett (2005–2021), and Stephen Lye (2021–).

Funding

Researchers are supported by the Mount Sinai Hospital Foundation, donors and external funding sources including: [2]

Related Research Articles

<span class="mw-page-title-main">University of Toronto Faculty of Medicine</span> Medical school of the University of Toronto

The Temerty Faculty of Medicine is the medical school of the University of Toronto. Founded in 1843, the faculty is based in Downtown Toronto and is one of Canada's oldest institutions of medical studies, being known for the discovery of insulin, stem cells and the site of the first single and double lung transplants in the world.

Mount Sinai Hospital (MSH) is a hospital in Toronto, Ontario, Canada. Mount Sinai is part of Sinai Health. Sinai Health was formed through the voluntary amalgamation of Mount Sinai Hospital and Hennick Bridgepoint Hospital on January 22, 2015.

<span class="mw-page-title-main">Princess Margaret Cancer Centre</span> Hospital in Ontario, Canada

The Princess Margaret Cancer Centre is a scientific research centre and a teaching hospital in Toronto, Ontario, Canada, affiliated with the University of Toronto Faculty of Medicine as part of the University Health Network. The hospital now stands as the largest cancer centre in Canada and one of the five largest cancer centres in the world. Along with the Odette Cancer Centre, which is also associated with University of Toronto Faculty of Medicine and is independently the sixth largest cancer centre in North America, it forms one of the largest cluster of cancer hospitals in the world.

<span class="mw-page-title-main">Mount Sinai Hospital (Manhattan)</span> Hospital in New York, United States

Mount Sinai Hospital, founded in 1852, is one of the oldest and largest teaching hospitals in the United States. It is located in East Harlem in the New York City borough of Manhattan, on the eastern border of Central Park stretching along Madison and Fifth Avenues, between East 98th Street and East 103rd Street. The entire Mount Sinai health system has over 7,400 physicians, as well as 3,919 beds, and delivers over 16,000 babies a year.

<span class="mw-page-title-main">Louis Siminovitch</span> Canadian biologist (1970–2021)

Louis Siminovitch was a Canadian molecular biologist. He was a pioneer in human genetics, researcher into the genetic basis of muscular dystrophy and cystic fibrosis, and helped establish Ontario programs exploring genetic roots of cancer.

<span class="mw-page-title-main">Tony Pawson (biochemist)</span> British-born Canadian scientist

Anthony James Pawson was a British-born Canadian scientist.

Lawrence M. Tanenbaum is a Canadian businessman and chairman of Maple Leaf Sports & Entertainment (MLSE). He owns a 25% stake in MLSE through his holding company Kilmer Sports Inc.

<span class="mw-page-title-main">Icahn School of Medicine at Mount Sinai</span> American medical school

The Icahn School of Medicine at Mount Sinai, formerly the Mount Sinai School of Medicine, is a private medical school in New York City, New York, United States. The school is the academic teaching arm of the Mount Sinai Health System, which manages eight hospital campuses in the New York metropolitan area, including Mount Sinai Hospital and the New York Eye and Ear Infirmary.

<span class="mw-page-title-main">BioGRID</span> Biological database

The Biological General Repository for Interaction Datasets (BioGRID) is a curated biological database of protein-protein interactions, genetic interactions, chemical interactions, and post-translational modifications created in 2003 (originally referred to as simply the General Repository for Interaction Datasets by Mike Tyers, Bobby-Joe Breitkreutz, and Chris Stark at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital. It strives to provide a comprehensive curated resource for all major model organism species while attempting to remove redundancy to create a single mapping of data. Users of The BioGRID can search for their protein, chemical or publication of interest and retrieve annotation, as well as curated data as reported, by the primary literature and compiled by in house large-scale curation efforts. The BioGRID is hosted in Toronto, Ontario, Canada and Dallas, Texas, United States and is partnered with the Saccharomyces Genome Database, FlyBase, WormBase, PomBase, and the Alliance of Genome Resources. The BioGRID is funded by the NIH and CIHR. BioGRID is an observer member of the International Molecular Exchange Consortium.

<span class="mw-page-title-main">Piers Nash</span>

Piers David Nash is an entrepreneur, cancer biology professor, data evangelist, writer and technology futurist. He was the founder of Sympatic, and the son of academic Roger Nash.

The Stem Cell Network (SCN) is a Canadian non-profit that supports stem cell and regenerative medicine research, teaches the next generation of highly qualified personal, and delivers outreach activities across Canada. The Network has been supported by the Government of Canada, since inception in 2001. SCN has catalyzed 25 clinical trials, 21 start-up companies, incubated several international and Canadian research networks and organizations, and established the Till & McCulloch Meetings, Canada's foremost stem cell research event.

Graham Leon Collingridge is a British neuroscientist and professor at the University of Toronto and at the University of Bristol. He is also a senior investigator at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto.

<span class="mw-page-title-main">Daniel J. Drucker</span> Canadian endocrinologist (born 1956)

Daniel Joshua Drucker is a Canadian endocrinologist. A Fellow of the Royal Society, he is a professor of medicine at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto. He is known for his research into intestinal hormones and their use in the treatment of diabetes, obesity, and other metabolic diseases, as well as intestinal failure.

<span class="mw-page-title-main">Sinai Health System</span> Hospital in Ontario, Canada

The Sinai Health System is a hospital system which serves Toronto, Ontario, Canada. It comprises two hospitals, Mount Sinai Hospital and Hennick Bridgepoint Hospital, both affiliated with the University of Toronto Faculty of Medicine.

The Global Alliance for Genomics and Health (GA4GH) is an international consortium that is developing standards for responsibly collecting, storing, analyzing, and sharing genomic data in order to enable an "internet of genomics". GA4GH was founded in 2013.

Bernard Zinman is a Canadian clinical and research endocrinologist, whose research at the University of Toronto focuses on type 1 and type 2 diabetes. He directed the Mount Sinai Hospital Leadership Sinai Centre for Diabetes and the Banting and Best Diabetes Centre. In 2019, he was appointed as an Officer to the Order of Canada in recognition of his scientific contributions, including the development of preventative therapies for diabetes.

James (Jim) Woodgett is a British-born biologist and the Principal Investigator of an active research laboratory at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System, in Toronto, Ontario, Canada. He was the Koffler Director of Research at the Lunenfeld-Tanenbaum Research Institute from November 2005 to January 2021.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

Jeffrey L. Wrana is a Canadian cancer researcher. He is the CIBC Breast Cancer Research Scientist and Mary Janigan Research Chair in Molecular Cancer Therapeutic at Mount Sinai Hospital and University of Toronto. As a Tier 1 Canada Research Chair in Medical Genetics and Microbiology at U of T, Wrana was elected a Fellow of the Royal Society of Canada.

Ken Croitoru is a Canadian gastroenterologist who works at Mount Sinai Hospital in Toronto, a scientist at the Lunenfeld-Tanenbaum Research Institute, and a professor in the Department of Medicine at the University of Toronto. He is best known for his leadership of the Genetic, Environmental, Microbial (GEM) Project, a comprehensive research initiative aiming to understand the triggers of Crohn's disease.

References

  1. Researchers
  2. "Funding | WIHR". Lunenfeld-Tanenbaum Research Institute. Archived from the original on 2023-03-14. Retrieved 2023-03-14.

43°39′27″N79°23′22″W / 43.657367°N 79.389557°W / 43.657367; -79.389557